Genome editing using CRISPR-Cas9 system shows tremendous promise
Research published in Nature Medicine describes collaborative effort to reduce off-target CRISPR-Cas9 genome editing, removing…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
ALEX provides guaranteed express delivery of pharma goods cost-effectively
Virendra Chaudhary, Director, Algor Logistics in a tête-à-tête with Express Pharma, speaks on the crucial role played by…
Eisai/Biogen to advance Alzheimer’s drug, provide fresh hope
According to Eisai, the company had already contacted various regulators and plans to pursue accelerated approvals
Healing beyond boundaries, against all odds
In Part Two of our Independence Day coverage, we identify trade and non-trade barriers faced by India Pharma Inc as it seeks to…
Direct to consumer advertising of medicines and medical devices — a call for action!
Dr Milind Antani, Anay Shukla and Darren Punnen from Nishith Desai Associates, give an insight on the scope of laws that regulate…
Customer Voice – It means business!
Mohan G Joshi, International Business Coach and Former President, SCHOTT Glass India elaborates on unlocking the hitherto untapped…
Epygen Biotech, first company in India to acquire licensing of Novel Biological Entity (NBE)
The company has acquired the exclusive licensing of NBE from CSIR-IMTECH for treatment of Ischemic strokes
Players in global cancer supportive care products market focus on getting approvals from governing…
Leading manufacturers are enhancing their business operations and encouraging R&D activities
Ind AS 115 – Key impact for life sciences entities
Jalpa Sonchhatra, Director, Financial Accounting Advisory Services, EY India speaks on the strategies needed to ensure compliance…
Morepen Labs begins FY 2018-19 with sound performance in first quarter
Company reports 93 percent rise in its consolidated net profit and 26 percent rise in its consolidated net sales revenue in Q1 of…